GNS Technologies Revenue and Competitors
Estimated Revenue & Valuation
- GNS Technologies's estimated annual revenue is currently $2.3M per year.
- GNS Technologies's estimated revenue per employee is $105,000
Employee Data
- GNS Technologies has 22 Employees.
- GNS Technologies grew their employee count by 5% last year.
GNS Technologies's People
| Name | Title | Email/Phone |
|---|
GNS Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.3M | 22 | 5% | N/A | N/A |
#2 | $4.3M | 36 | -28% | N/A | N/A |
#3 | $5.8M | 48 | 2% | N/A | N/A |
#4 | $16.8M | 112 | -3% | $4M | N/A |
#5 | $6M | 50 | N/A | N/A | N/A |
#6 | $1.3M | 14 | 8% | N/A | N/A |
#7 | $0.5M | 7 | N/A | N/A | N/A |
#8 | $15.5M | 103 | 6% | N/A | N/A |
What Is GNS Technologies?
GNS Technologies is one of the leading IT training institutes based in Pune. It is managed by a group of IT and education experts with a strong aim of fulfilling the industry demand of quality hardware and network professionals. We provide real-time training on high-end technology in Hardware, Networking and IT Security Industry.
keywords:N/A
N/A
Total Funding
22
Number of Employees
$2.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GNS Technologies News
Clarify Health Solutions; BioXcel Therapeutics; Ada Health GmbH; GNS Healthcare; Zebra Medical Vision Inc; Qventus Inc; IDx Technologies Inc.
GNS has operated in Japan for more than 30 years, and the consortium will bring new geothermal expertise into Japan, including technology...
NanoString Technologies (NASDAQ:NSTG) stock is plummeting more than 32% after ... Genius Group (NYSEAMERICAN:GNS) shares are diving over 21%...
Other Companies in Pune
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 22 | 16% | N/A |
#2 | $1.3M | 22 | -15% | N/A |
#3 | $1.9M | 22 | -15% | N/A |
#4 | $1.1M | 22 | N/A | N/A |
#5 | $2.2M | 22 | 5% | N/A |